<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Cardiovascular Drugs | Pharmacology</title>
    
    <!-- Preconnect for performance -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    
    <!-- Google Fonts -->
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <!-- Main Stylesheet -->
    <link rel="stylesheet" href="../styles/main.css">
    
    <!-- MathJax Configuration -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true
        },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <!-- Skip Link -->
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <!-- Reading Progress Bar -->
    <div class="reading-progress-container" aria-hidden="true">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <!-- Theme Toggle -->
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode" title="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="page-wrapper">
        <!-- Floating Mini-TOC -->
        <aside class="floating-toc" id="floating-toc" aria-label="On this page">
            <div class="floating-toc-header">
                <span class="floating-toc-icon">üìë</span>
                <span>On this page</span>
            </div>
            <nav class="floating-toc-nav">
                <ul class="floating-toc-list">
                    <!-- Links populated by JS -->
                </ul>
            </nav>
        </aside>

        <div class="container">
            <article class="document-article" role="main" id="main-content">
                <!-- Top Navigation -->
                <nav class="document-nav" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="../index.html" class="nav-button nav-button--toc" aria-label="Table of Contents">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">Contents</span>
                        </a>
                        
                        <a href="topic-08-blood-drugs.html" class="nav-button nav-button--prev" aria-label="Previous section">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span class="progress-current">9</span>
                                <span class="progress-separator">/</span>
                                <span class="progress-total">16</span>
                            </div>
                            <div class="progress-bar-container" aria-hidden="true">
                                <div class="progress-bar-fill" style="width: 56%;"></div>
                            </div>
                            <span class="progress-label">Cardiovascular Drugs</span>
                        </div>
                        
                        <a href="topic-10-antihypertensives.html" class="nav-button nav-button--next" aria-label="Next section">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>

                <!-- Breadcrumb -->
                <nav class="breadcrumb" aria-label="Breadcrumb">
                    <ol class="breadcrumb-list">
                        <li class="breadcrumb-item"><a href="../index.html">Home</a></li>
                        <li class="breadcrumb-item active" aria-current="page">Cardiovascular Drugs</li>
                    </ol>
                </nav>

                <!-- Document Header -->
                <header class="document-header">
                    <div class="header-badge">
                        <span class="badge-icon">‚ù§Ô∏è</span>
                        <span class="badge-text">Unit 9</span>
                    </div>
                    <h1 class="document-title">Cardiac Drugs</h1>
                    <div class="title-meta">
                        <span class="meta-item">
                            <span class="meta-icon">üìÑ</span>
                            <span>Pages 64-69</span>
                        </span>
                        <span class="meta-item">
                            <span class="meta-icon">‚è±Ô∏è</span>
                            <span>15 min read</span>
                        </span>
                    </div>
                </header>

                <!-- Main Content -->
                <div class="content-wrapper">
                    <!-- START: cardiac-glycosides -->
                    <section id="cardiac-glycosides" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">01</div>
                            <h2 class="section-title">Cardiac glycosides</h2>
                        </div>
                        
                        <div class="content-card">
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker">‚ñ™</span><span class="list-content">Digitoxins are plant alkaloids.</span></li>
                                <li class="list-item"><span class="list-marker">‚ñ™</span><span class="list-content">They increase myocardial contractions, which will increase blood supply to all organs including the kidneys therefore causing diuresis, which will decrease the edema.</span></li>
                                <li class="list-item"><span class="list-marker">‚ñ™</span><span class="list-content">They are used to treat cardiac arrhythmia because they decrease heart rate.</span></li>
                            </ul>
                        </div>

                        <h3>Action:</h3>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="list-marker">‚ñ™</span><span class="list-content">They increase the force of myocardial contractions (positive inotropic).</span></li>
                            <li class="list-item"><span class="list-marker">‚ñ™</span><span class="list-content">They increase the contractility of the heart muscle by minimizing the movement of Na and K ions and increasing the release of Ca ions in the myocardial cells.</span></li>
                            <li class="list-item"><span class="list-marker">‚ñ™</span><span class="list-content">It decreases the heart rate due to increase in parasympathetic nervous system and decrease in the sympathetic tone.</span></li>
                            <li class="list-item"><span class="list-marker">‚ñ™</span><span class="list-content">They are primarily excreted through the kidneys.</span></li>
                            <li class="list-item"><span class="list-marker">‚ñ™</span><span class="list-content">The initial dose is the larger dose (the loading or digitalizing dose), the subsequent doses are referred to as (Maintenance doses).</span></li>
                        </ul>

                        <h3>Results:</h3>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="list-marker">‚ñ™</span><span class="list-content">Decrease in venous pressure.</span></li>
                            <li class="list-item"><span class="list-marker">‚ñ™</span><span class="list-content">Coronary dilatation.</span></li>
                            <li class="list-item"><span class="list-marker">‚ñ™</span><span class="list-content">Reduce heart size.</span></li>
                            <li class="list-item"><span class="list-marker">‚ñ™</span><span class="list-content">Marked diuresis and decreasing edema.</span></li>
                        </ul>

                        <h3>Indications:</h3>
                        <ol class="enhanced-list">
                            <li class="list-item"><span class="list-marker">1</span><span class="list-content">Congestive heart failure (C.H.F).</span></li>
                            <li class="list-item"><span class="list-marker">2</span><span class="list-content">Cardiac arrhythmia (atrial fibrillation, atrial flutter and sinus tachycardia.</span></li>
                        </ol>

                        <h3>Contraindication:</h3>
                        <ol class="enhanced-list">
                            <li class="list-item"><span class="list-marker">1</span><span class="list-content">Hypersensitivity.</span></li>
                            <li class="list-item"><span class="list-marker">2</span><span class="list-content">Angina pectoris in absence of CHF.</span></li>
                            <li class="list-item"><span class="list-marker">3</span><span class="list-content">Given with caution for elderly and people who have kidney failure.</span></li>
                        </ol>

                        <div class="callout callout--danger">
                            <div class="callout-header"><span class="callout-icon">‚ò¢Ô∏è</span><span class="callout-title">Side effects</span></div>
                            <div class="callout-content">
                                <ol>
                                    <li>They are extremely toxic and may cause death.</li>
                                    <li>There is a narrow margin of safety between the therapeutic dose and the toxic dose.</li>
                                    <li>Could cause overdose by cumulative effects of the drug so frequent assessment of the serum level is essential.</li>
                                    <li>May cause cardiac arrhythmia such as bradycardia (below than 60 beat /minute) and other dysarrhythmia.</li>
                                    <li>Nausea, vomiting, and diarrhea.</li>
                                    <li>Headache, malaise and muscle weakness.</li>
                                    <li>Skin rashes, blurring of vision, diplopia and while halos.</li>
                                </ol>
                            </div>
                        </div>

                        <aside class="callout callout--warning">
                            <div class="callout-header"><span class="callout-icon">‚ö†Ô∏è</span><span class="callout-title">Note</span></div>
                            <div class="callout-content">
                                <p>Patients suffering from digitalis intoxication should be admitted to the ICU for continuous monitoring of ECG. Administration of digitalis should be halted.</p>
                                <p>If serum potassium is below normal, administer K salts and give antiarrhythmic drugs as Lidocain as ordered by Dr.</p>
                            </div>
                        </aside>

                        <h3>Drug interactions:</h3>
                        <ol class="enhanced-list">
                            <li class="list-item"><span class="list-marker">1</span><span class="list-content">Antacid (they decrease the effect of digitalis).</span></li>
                            <li class="list-item"><span class="list-marker">2</span><span class="list-content">Fursemide (Lasix): it increase K loss and increase the chance for digitalis toxicity.</span></li>
                        </ol>

                        <div class="content-card">
                            <h4>Predisposing factors for digitalis toxicity:</h4>
                            <p><strong>1. K loss (hypokalemia)</strong> which results from: diuretics, NPO, gastric suction, and poor K intake.</p>
                            <p><strong>2. Pathological conditions;</strong></p>
                            <ul>
                                <li><strong>A) Liver disease:</strong> they decrease metabolism and therefore increase digitalis level.</li>
                                <li><strong>B) Kidney disease:</strong> they decrease the excretion of drug and therefore increase digitalis levels.</li>
                            </ul>
                        </div>

                        <aside class="callout callout--info">
                            <div class="callout-header"><span class="callout-icon">üë©‚Äç‚öïÔ∏è</span><span class="callout-title">Nursing considerations</span></div>
                            <div class="callout-content">
                                <ul>
                                    <li>Check doctor‚Äôs order, medication record and bottle label accurately.</li>
                                    <li>Observe monitor for evidence of bradycardia or arrhythmia.</li>
                                    <li>Measure intake and output accurately.</li>
                                    <li>Weigh the patient in daily basis.</li>
                                    <li>Pulse should be checked by 2 nurses.</li>
                                    <li>Provide the client with foods high in potassium as banana, orange.</li>
                                    <li>Monitor serum digoxin level.</li>
                                    <li>Elderly people should be assessed for early signs of toxicity.</li>
                                    <li>Have digoxin antidote available (digoxin immune FAB).</li>
                                </ul>
                            </div>
                        </aside>

                        <div class="content-card">
                            <h4>Digoxin: Lanoxin</h4>
                            <p><strong>Class:</strong> cardiac glycoside.</p>
                            <p>It is the drug of choice for CHF because of:</p>
                            <ol>
                                <li>It has rapid onset.</li>
                                <li>It has short duration.</li>
                                <li>It can be administered P.O. or IV.</li>
                            </ol>
                            <p><strong>Dose:</strong> digitalization dose = 0.4 ‚Äì 0.6 mg followed by 0.05 ‚Äì 0.35 mg once or twice daily.</p>
                            <p><strong>Antidote:</strong> Digoxin Immune FAB (Ovine)</p>
                        </div>
                    </section>
                    <!-- END: cardiac-glycosides -->

                    <!-- START: coronary-vasodilators -->
                    <section id="coronary-vasodilators" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">02</div>
                            <h2 class="section-title">Coronary vasodilators</h2>
                        </div>

                        <h3>1. Antianginal drugs</h3>
                        <div class="content-card">
                            <p><strong>‚ùñAngina pectoris:</strong> is a clinical syndrome characterized by paroxysm of pain in the anterior chest caused by insufficient coronary blood flow and/or inadequate oxygen supply to the myocardial muscle.</p>
                            <p><strong>Causes:</strong> (1) Atherosclerosis. (2) Vasospasim.</p>
                        </div>

                        <p><strong>‚ùñThere are three groups of drugs used for treatment of angina:</strong></p>
                        <ol>
                            <li>Nitrates/nitrites.</li>
                            <li>Beta-adrenergic blocking agents.</li>
                            <li>Calcium channel blocking agents.</li>
                        </ol>

                        <h3>Nitrates/nitrites:</h3>
                        <p><strong>- Nitrates/nitrites - Action:</strong> direct relaxation of blood vessels and smooth muscles vasodialtion O2 requirements.</p>
                        <ul>
                            <li>relaxation of smooth muscles of coronary arteries coronary vasodialtion blood supply to the myocardium.</li>
                            <li>relaxation of arteries and veins BP workload in the heart.</li>
                        </ul>

                        <div class="content-card">
                            <h4>Indications:</h4>
                            <ol>
                                <li>Prophylaxis and treatment of acute angina pectoris.</li>
                                <li>Treatment of chronic angina pectoris.</li>
                                <li>Treatment of hypertension associated with MI or CHF.</li>
                                <li>Nitroglycerin ointment for treatment of Raynaud‚Äôs disease.</li>
                            </ol>
                        </div>

                        <div class="callout callout--danger">
                            <div class="callout-header"><span class="callout-icon">üö´</span><span class="callout-title">Contraindications</span></div>
                            <div class="callout-content">
                                <ol>
                                    <li>Sensitivity to nitrates Hypotension.</li>
                                    <li>Severe anemia.</li>
                                    <li>Hypotension.</li>
                                    <li>Head trauma.</li>
                                    <li>Cerebral hemorrhage.</li>
                                </ol>
                            </div>
                        </div>

                        <p><strong>‚ùñSide effects:</strong></p>
                        <ol>
                            <li>Headache, syncope, dizziness.</li>
                            <li>Postural hypotension, transient flushing, and palpitation.</li>
                            <li>Topical application may lead to dermatistis.</li>
                        </ol>

                        <p><strong>‚ùñDrug interaction:</strong> Antihypertensive agents, Beta-adrenergic blocking agents, and calcium-channel blocking agent (they may lead to additive hypotension.</p>

                        <p><strong>‚ùñDosage: there are several forms available:</strong></p>
                        <ol>
                            <li>Sublingual: Cordil 5 mg PRN.</li>
                            <li>PO: Isotard 20 ‚Äì 40 mg twice a day.</li>
                            <li>Topical: avilable as patches or ointment.</li>
                            <li>Parental (IV infusion).</li>
                        </ol>

                        <aside class="callout callout--info">
                            <div class="callout-header"><span class="callout-icon">üë©‚Äç‚öïÔ∏è</span><span class="callout-title">Nursing considerations:</span></div>
                            <div class="callout-content">
                                <ol>
                                    <li>medications should be taken on an empty stomach.</li>
                                    <li>Carry sublingual tablets in a glass bottle, tightly capped.</li>
                                    <li>If anginal pain is not relieved in 5 minutes by first sublingual tablet, to take up to 2 more tablets at 5 minutes interval. If pain has not subsided 5 minutes after the 3rd tablet, client should be taken to the emergency room.</li>
                                    <li>Take sublingual tablets 5-15 minutes prior to any situation likely to cause anginal pain such as climbing stairs.</li>
                                    <li>Take sublingual tablets while sitting to avoid postural hypotension.</li>
                                </ol>
                            </div>
                        </aside>

                        <div class="content-card">
                            <h4>Isosorbide dinitrate:</h4>
                            <p>- Present in the forms of capsules chewable, sublingual, tablets.</p>
                            <p>- <strong>Trade names:</strong> Cordil, Isotard.</p>
                            <p>- <strong>Class:</strong> coronary vasodialtor.</p>
                            <p>- <strong>Dosage forms:</strong> caps 20-40 mg, tabs 20-40 mg.</p>
                            <p>- <strong>Uses:</strong></p>
                            <ul>
                                <li>Tabs for only prophylaxis of anginal pain.</li>
                                <li>Chewable, sublingual to terminate acute attack and relieve acute pain.</li>
                                <li>Esophageal spasm.</li>
                            </ul>
                            <p>- <strong>Side effects:</strong> Headache, hypotensioin.</p>
                            <p>- <strong>Dosage:</strong></p>
                            <ul>
                                <li>Sublingual: acute attack 2.5-5 mg Q 2-3 hrs.</li>
                                <li>Oral caps/tabs: 5-20 mg Q 6 hrs.</li>
                                <li>Extended release tabs: 20 ‚Äì80 mg Q 8-12 hrs.</li>
                            </ul>
                            <p>- <strong>Note:</strong> Isosorbide mononitrate given for patients with liver impairments.</p>
                        </div>
                    </section>
                    <!-- END: coronary-vasodilators -->

                    <!-- START: calcium-channel-blockers -->
                    <section id="calcium-channel-blockers" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">03</div>
                            <h2 class="section-title">Calcium channel blocking agents</h2>
                        </div>
                        <p><strong>- Action:</strong> for contraction of cardiac and smooth muscle to occur, extracellular calcium must move into the cell through openings called calcium channels. These agents inhibit the influx of calcium through the cell membrane resulting in a depression of automatically and conduction velocity in both smooth and cardiac muscles leading to:</p>
                        <ol class="enhanced-list">
                            <li class="list-item"><span class="list-marker">1</span><span class="list-content">Myocardial contractility. .</span></li>
                            <li class="list-item"><span class="list-marker">2</span><span class="list-content">Inhibit spasm of coronary arteries dilatation.</span></li>
                            <li class="list-item"><span class="list-marker">3</span><span class="list-content">Peripheral vasodilatation peripheral resistance.</span></li>
                            <li class="list-item"><span class="list-marker">4</span><span class="list-content">S. A. node automatically and conduction heart rate.</span></li>
                        </ol>

                        <div class="content-card">
                            <h4>Nifedipine: Adalat</h4>
                            <p>- <strong>Class:</strong> calcium channel blocking agent (anti-angina, antihypertensive).</p>
                            <p>- <strong>Uses:</strong> vasospastic angina, essential hypertension.</p>
                            <p>- <strong>Contraindications:</strong> hypersensitivity, lactation.</p>
                            <p>- <strong>Side effects:</strong> pulmonary and peripheral edema, MI, hypotension, headache, muscle cramps, flushing.</p>
                            <p>- <strong>Dosage:</strong> 10- 30 mg tid.</p>
                            <p>- In hypertensive emergencies: 10-20 mg given orally or sublingually by puncturing the capsule and squeezing contents under the tongue.</p>
                        </div>

                        <div class="content-card">
                            <h4>Verapamil: Ikacor</h4>
                            <p>- <strong>Class:</strong> calcium channel blocking agent (anti-angina, antihypertensive).</p>
                            <p>- <strong>Uses:</strong></p>
                            <ul>
                                <li>P.O: angina pectoris, arrhythmia (atrial fibrillation, and flutter).</li>
                                <li>Essential hypertension.</li>
                                <li>IV: supraventricular tachycardia.</li>
                            </ul>
                            <p>- <strong>Contraindications:</strong> hypotension, cardiac shock, and MI.</p>
                            <p>- <strong>Side effects:</strong> AV block, bradycardia, headache, dizziness, abdominal cramps, blurring of vision, and edema. .</p>
                            <p>- <strong>Dosage:</strong> Initial 80-120 mg tid then 240-480 mg /day.</p>
                        </div>

                        <aside class="callout callout--info">
                            <div class="callout-header"><span class="callout-icon">üë©‚Äç‚öïÔ∏è</span><span class="callout-title">Nursing considerations for calcium channel blocking agents:</span></div>
                            <div class="callout-content">
                                <ol>
                                    <li>Discuss with the patient/family the goals of therapy.</li>
                                    <li>Teach them how to take pulse and blood pressure. Hold the medication in case of hypotension or bradycardia and consult the treating Dr.</li>
                                    <li>Instruct the client to report any untoward sings as dizziness.</li>
                                    <li>In case of postural hypotension, advise the client to change position.</li>
                                    <li>Advise client to sit down immediately if fainting occurs.</li>
                                    <li>Calcium antagonists should be taken with meals to GI irritation.</li>
                                </ol>
                            </div>
                        </aside>
                    </section>
                    <!-- END: calcium-channel-blockers -->

                    <!-- START: antihypertensives-intro -->
                    <section id="antihypertensives-intro" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">04</div>
                            <h2 class="section-title">Antihypertensive drugs</h2>
                        </div>
                        <p><strong>‚ùñHypertension:</strong> is a condition in which the mean arterial blood pressure is elevated.</p>
                        <p><strong>‚ùñEssential hypertension:</strong> could be mild, moderate, or sever and may lead to dangerous changes in kidneys, eyes and blood vessels.</p>
                        <p><strong>‚ùñSecondary hypertension:</strong> a certain disease or condition leads to elevation of blood pressure such as toxemia or pregnancy, acute kidney failure, etc.</p>
                        <p><strong>‚ùñAntihypertensive agents:</strong> are initiated when diastolic blood pressure is higher that 90mm/Hg.</p>
                        
                        <div class="content-card">
                            <h4>‚ùñTreatment of hypertension includes:</h4>
                            <ol class="enhanced-list">
                                <li class="list-item"><span class="list-marker">1</span><span class="list-content">weight reduction.</span></li>
                                <li class="list-item"><span class="list-marker">2</span><span class="list-content">Sodium restriction.</span></li>
                                <li class="list-item"><span class="list-marker">3</span><span class="list-content">Alcohol restriction.</span></li>
                                <li class="list-item"><span class="list-marker">4</span><span class="list-content">Stop smoking.</span></li>
                                <li class="list-item"><span class="list-marker">5</span><span class="list-content">Exercise.</span></li>
                                <li class="list-item"><span class="list-marker">6</span><span class="list-content">Behavior modification.</span></li>
                            </ol>
                        </div>

                        <p><strong>‚ùñSingle drug should be considered from the following classes:</strong></p>
                        <!-- Note: Specific drug classes are listed on the next page (101) in the original document, which continues in the next topic file. -->
                    </section>
                    <!-- END: antihypertensives-intro -->

                </div>

                <!-- Bottom Navigation -->
                <nav class="document-nav document-nav--bottom" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="topic-08-blood-drugs.html" class="nav-button nav-button--prev nav-button--large">
                            <span class="nav-icon">‚Üê</span>
                            <div class="nav-content">
                                <span class="nav-label">Previous</span>
                                <span class="nav-title">Blood Formation & Coagulation</span>
                            </div>
                        </a>
                        
                        <a href="../index.html" class="nav-button nav-button--toc">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">All Topics</span>
                        </a>
                        
                        <a href="topic-10-antihypertensives.html" class="nav-button nav-button--next nav-button--large">
                            <div class="nav-content">
                                <span class="nav-label">Next</span>
                                <span class="nav-title">Antihypertensives</span>
                            </div>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <!-- Scripts -->
    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>